questionsmedicales.fr
Troubles dus à des produits chimiques
Effets secondaires indésirables des médicaments
Syndrome anticholinergique
Syndrome anticholinergique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Syndrome anticholinergique
Diagnostic médical
Tests diagnostiques
Syndrome anticholinergique
Signes cliniques
Syndrome anticholinergique
Troubles neurologiques
Syndrome anticholinergique
Historique médical
Syndrome anticholinergique
Symptômes
5
Symptômes
Syndrome anticholinergique
Sécheresse buccale
Syndrome anticholinergique
Mydriase
Syndrome anticholinergique
Troubles de la mémoire
Syndrome anticholinergique
Tachycardie
Syndrome anticholinergique
Prévention
5
Prévention
Syndrome anticholinergique
Personnes âgées
Syndrome anticholinergique
Inhibiteurs de la recapture
Syndrome anticholinergique
Éducation des patients
Syndrome anticholinergique
Interactions médicamenteuses
Syndrome anticholinergique
Traitements
5
Traitement
Syndrome anticholinergique
Antidotes
Syndrome anticholinergique
Gestion des symptômes
Syndrome anticholinergique
Hospitalisation
Syndrome anticholinergique
Médicaments
Syndrome anticholinergique
Complications
5
Complications
Syndrome anticholinergique
Hospitalisations
Syndrome anticholinergique
Risque de décès
Syndrome anticholinergique
Gestion des complications
Syndrome anticholinergique
Complications neurologiques
Syndrome anticholinergique
Facteurs de risque
5
Facteurs de risque
Syndrome anticholinergique
Antécédents médicaux
Syndrome anticholinergique
Médicaments psychotropes
Syndrome anticholinergique
Interactions médicamenteuses
Syndrome anticholinergique
Sexe
Syndrome anticholinergique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome anticholinergique : Questions médicales les plus fréquentes",
"headline": "Syndrome anticholinergique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome anticholinergique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2026-02-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome anticholinergique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Effets secondaires indésirables des médicaments",
"url": "https://questionsmedicales.fr/mesh/D064420",
"about": {
"@type": "MedicalCondition",
"name": "Effets secondaires indésirables des médicaments",
"code": {
"@type": "MedicalCode",
"code": "D064420",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C25.100"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome anticholinergique",
"alternateName": "Anticholinergic Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D064807",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Delia Bishara",
"url": "https://questionsmedicales.fr/author/Delia%20Bishara",
"affiliation": {
"@type": "Organization",
"name": "Mental Health of Older Adults and Dementia, South London and Maudsley NHS Foundation Trust, London, UK Delia.Bishara@slam.nhs.uk."
}
},
{
"@type": "Person",
"name": "David Sheyn",
"url": "https://questionsmedicales.fr/author/David%20Sheyn",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sherif El-Nashar",
"url": "https://questionsmedicales.fr/author/Sherif%20El-Nashar",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Tobias Hölle",
"url": "https://questionsmedicales.fr/author/Tobias%20H%C3%B6lle",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Deutschland."
}
},
{
"@type": "Person",
"name": "Jan C Purrucker",
"url": "https://questionsmedicales.fr/author/Jan%20C%20Purrucker",
"affiliation": {
"@type": "Organization",
"name": "Neurologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Postoperative cognitive dysfunction: a concept analysis.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38902462",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40520-024-02779-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microvascular Dysfunction as a Possible Link Between Heart Failure and Cognitive Dysfunction.",
"datePublished": "2023-09-26",
"url": "https://questionsmedicales.fr/article/37750336",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/CIRCHEARTFAILURE.122.010117"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of epigenetic modification in postoperative cognitive dysfunction.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37321381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.arr.2023.101983"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37834094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241914647"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome.",
"datePublished": "2024-03-30",
"url": "https://questionsmedicales.fr/article/38674375",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes15040440"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles dus à des produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D064419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Effets secondaires indésirables des médicaments",
"item": "https://questionsmedicales.fr/mesh/D064420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome anticholinergique",
"item": "https://questionsmedicales.fr/mesh/D064807"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome anticholinergique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome anticholinergique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome anticholinergique",
"description": "Comment diagnostiquer le syndrome anticholinergique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres conditions ?\nQuelle est l'importance de l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D064807?mesh_terms=Cognitive+Dysfunction#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome anticholinergique",
"description": "Quels sont les symptômes principaux du syndrome ?\nComment se manifeste la sécheresse buccale ?\nQu'est-ce que la mydriase ?\nLe syndrome peut-il provoquer des troubles de la mémoire ?\nQuels effets sur le rythme cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D064807?mesh_terms=Cognitive+Dysfunction#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome anticholinergique",
"description": "Comment prévenir le syndrome anticholinergique ?\nLes personnes âgées sont-elles plus à risque ?\nQuelles alternatives aux anticholinergiques ?\nComment éduquer les patients sur les risques ?\nLes interactions médicamenteuses sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D064807?mesh_terms=Cognitive+Dysfunction#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome anticholinergique",
"description": "Quel est le traitement principal du syndrome ?\nDes antidotes existent-ils pour ce syndrome ?\nComment gérer les symptômes ?\nLe traitement nécessite-t-il une hospitalisation ?\nQuels médicaments peuvent aggraver le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D064807?mesh_terms=Cognitive+Dysfunction#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome anticholinergique",
"description": "Quelles complications peuvent survenir ?\nLe syndrome peut-il entraîner des hospitalisations ?\nY a-t-il un risque de décès ?\nComment les complications sont-elles gérées ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D064807?mesh_terms=Cognitive+Dysfunction#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome anticholinergique",
"description": "Quels sont les principaux facteurs de risque ?\nLes antécédents médicaux influencent-ils le risque ?\nL'usage de médicaments psychotropes est-il un facteur ?\nLes interactions médicamenteuses augmentent-elles le risque ?\nLe sexe influence-t-il le risque de syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D064807?mesh_terms=Cognitive+Dysfunction#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome anticholinergique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique des médicaments pris."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun test spécifique, mais des analyses peuvent exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, sécheresse buccale, mydriase et tachycardie."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres conditions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des troubles neurologiques ou psychiatriques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique aide à identifier les médicaments anticholinergiques responsables."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, hallucinations, sécheresse et tachycardie."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la sécheresse buccale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sécheresse buccale se traduit par une sensation de bouche sèche et des difficultés à avaler."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la mydriase ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mydriase est une dilatation anormale des pupilles, fréquente dans ce syndrome."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il provoquer des troubles de la mémoire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la mémoire et de la concentration peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets sur le rythme cardiaque ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le syndrome peut entraîner une tachycardie, augmentant le rythme cardiaque."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome anticholinergique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'utilisation excessive de médicaments anticholinergiques et surveiller les prescriptions."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus sensibles aux effets des anticholinergiques."
}
},
{
"@type": "Question",
"name": "Quelles alternatives aux anticholinergiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des alternatives comme les inhibiteurs de la recapture de la sérotonine peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer les patients des effets secondaires potentiels des médicaments prescrits."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les interactions avec d'autres médicaments peuvent augmenter le risque de syndrome."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à arrêter les médicaments anticholinergiques responsables."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour ce syndrome ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physostigmine peut être utilisée comme antidote dans certains cas."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut l'hydratation et des médicaments pour soulager les effets."
}
},
{
"@type": "Question",
"name": "Le traitement nécessite-t-il une hospitalisation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité des symptômes; une hospitalisation peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aggraver le syndrome ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres médicaments anticholinergiques ou sédatifs peuvent aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles cardiaques, des chutes et des accidents vasculaires."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des hospitalisations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas de symptômes graves, une hospitalisation peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de décès ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans des cas extrêmes, le syndrome peut être fatal, surtout chez les personnes vulnérables."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une surveillance étroite et un traitement symptomatique."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques comme des convulsions peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'âge avancé, l'utilisation de plusieurs médicaments et des antécédents de troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies neurologiques augmentent le risque de syndrome."
}
},
{
"@type": "Question",
"name": "L'usage de médicaments psychotropes est-il un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les médicaments psychotropes peuvent augmenter le risque de syndrome anticholinergique."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent exacerber les effets anticholinergiques."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de syndrome ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les femmes peuvent être plus à risque que les hommes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/02/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Mental Health of Older Adults and Dementia, South London and Maudsley NHS Foundation Trust, London, UK Delia.Bishara@slam.nhs.uk.
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Publications dans "Syndrome anticholinergique" :
3 publications dans cette catégorie
Publications dans "Syndrome anticholinergique" :
3 publications dans cette catégorie
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Deutschland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Neurologische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Krankenhausapotheke, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Deutschland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Klinik für Anästhesiologie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Deutschland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Calle 105 No. 14-140, Pereira, Risaralda, Colombia Pereira, Risaralda, Colombia.
Grupo de Investigación Biomedicina, Fundación Universitaria Autónoma de las Américas, Ave Las Américas, # 98-56, Pereira, Colombia.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Calle 105 No. 14-140, Pereira, Risaralda, Colombia Pereira, Risaralda, Colombia.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Clinical Pharmacology and Appropriateness of Drug Prescription, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri, 2, 20156, Milan, Italy. luca.pasina@marionegri.it.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Division of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Department of Urogynaecology, Kings College Hospital, London, UK.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Department of Urogynaecology, Kings College Hospital, London, UK.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Clinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Center for Research and Innovation in Clinical Pharmaceutical Sciences, University Hospital and University of Lausanne, Lausanne, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Clinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Division of Occupational and Environmental Medicine, Epidemiology, Biostatistics and Prevention Institute, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Center for Research and Innovation in Clinical Pharmaceutical Sciences, University Hospital and University of Lausanne, Lausanne, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.
Publications dans "Syndrome anticholinergique" :
2 publications dans cette catégorie
Affiliations :
Clinical Pharmacy, Department Medical Services, Cantonal Hospital of Baden, Baden, Switzerland.
Swiss Federal Institute of Technology, Zurich, Switzerland.
Publications dans "Syndrome anticholinergique" :
Post-operative cognitive dysfunction (POCD) is a concern for clinicians that often presents post-surgery where generalized anesthesia has been used. Its prevalence ranges from 36.6% in young adults to...
The reporting of our review was guided by the PRISMA statement and the 6-step evolutionary approach to concept analysis developed by Rodgers. Three databases, including Medline, CINAHL, and Web of Sci...
POCD was defined with varying severities ranging from subtle-to-extensive cognitive changes (1) affecting single or multiple cognitive domains that manifest following major surgery (2), is transient a...
This review resulted in a refined definition and comprehensive analysis of POCD that can be useful to both researchers and clinicians. Future research is needed to refine the operational definitions o...
Microvascular function in the brain and heart may play an important role in the course of patients with heart failure (HF), but its relationship with ventricular and cognitive function is not well und...
In healthy controls and symptomatic patients with HF (New York Heart Association functional class II or III), we used oxygenation-sensitive magnetic resonance imaging during a standardized breathing m...
Twenty patients with HF (age 64.4±8.3 years; 50% female sex), and 21 healthy controls (age 55.0±5.1 years; 62% female sex) were included in the analysis. In patients with HF, cerebral oxygenation rese...
Our results indicate that heart failure is an independent predictor of coronary and cerebral microvascular dysfunction as defined by a reduced response to a vasodilatory breathing maneuver. This impai...
With the ageing of the population, the health problems of elderly individuals have become particularly important. Through a large number of clinical studies and trials, it has been confirmed that elde...
Cognitive dysfunction is an important non-motor symptom in amyotrophic lateral sclerosis (ALS) that has a negative impact on survival and caregiver burden. It shows a wide spectrum ranging from subjec...
22q11.2 Deletion Syndrome (22q11.2DS), the most common chromosomal microdeletion, presents as a heterogeneous phenotype characterized by an array of anatomical, behavioral, and cognitive abnormalities...
A growing body of literature suggests the important role of the thalamus in cognition and neurodegenerative diseases. This study aims to elucidate whether the preoperative thalamic volume is associate...
The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas...
A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ...
Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an...
Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...
Stroke survivors not only suffer from severe motor, speech and neurocognitive deficits, but in many cases also from a "lack of pleasure" and a reduced motivational level. Especially apathy and anhedon...
The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis....
To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients....
Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor...
A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in...
A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...
Cognitive dysfunction is increasingly recognized as a complication and comorbidity of diabetes, supported by evidence of abnormal brain structure and function. Although few mechanistic metabolic studi...